Mostrando 5,841 - 5,860 Resultados de 6,219 Para Buscar '"leishmaniasis"', tiempo de consulta: 0.25s Limitar resultados
  1. 5841
    “…BACKGROUND: Currently, there is no safe and effective vaccine against leishmaniasis and existing therapies are inadequate due to high toxicity, cost and decreased efficacy caused by the emergence of resistant parasite strains. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 5842
    “…Based on reported frequency in descending order, the bacterial NTDs were leprosy, Escherichia coli enteritis, salmonellosis, cholera, shigellosis, melioidosis, leptospirosis and rickettsioses; the viral NTDs were dengue, chikungunya and Japanese encephalitis virus (JEV) infection; the protozoal NTDs were amoebiasis, giardiasis and leishmaniasis, and the helminth NTDs were ascariasis, trichuriasis, hookworm disease, filariasis and strongyloidiasis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 5843
    por Cohen, Philip R
    Publicado 2023
    “…Human papillomavirus infection presenting as a verruca vulgaris is the most commonly associated infection; pox virus-related molluscum contagiosum is another viral infection that is less often observed associated with a cutaneous horn. Leishmaniasis, rhinosporidiosis, and cutaneous tuberculosis are rare cutaneous horn-related infections. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 5844
  5. 5845
    “…BACKGROUND: The trypanosomatids Leishmania major, Trypanosoma brucei and Trypanosoma cruzi cause some of the most debilitating diseases of humankind: cutaneous leishmaniasis, African sleeping sickness, and Chagas disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  6. 5846
    “…Topically administered nitric oxide has demonstrated to be effective and safe for the treatment of chronic ulcers secondary to cutaneous leishmaniasis. However, due to their unstable nitric oxide release, the topical donors needed to be applied frequently, diminishing the adherence to the treatment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  7. 5847
    Publicado 1994
    “…BALB/c mice infected with the intracellular protozoan Leishmania major mount a T helper cell 2 (Th2) response that fails to control growth of the parasite and results in the development of visceral leishmaniasis. Separation of CD4+ T cells into CD45RBhigh and CD45RBlow subsets showed that the L. major-specific Th2 cells were contained within the CD45RBlow population as these cells produced high levels of antigen- specific interleukin 4 (IL-4) in vitro and transferred a nonhealing response to L. major-infected C.B-17 scid mice. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  8. 5848
    Publicado 1995
    “…These results clearly point to an alternative strategy for the purification of proteins useful for the development of both vaccines and immunological diagnostic tools not only against leishmaniasis but also for other diseases caused by intracellular pathogens.…”
    Enlace del recurso
    Enlace del recurso
    Texto
  9. 5849
    “…Infected ICSBP-deficient mice developed fulminant, disseminated leishmaniasis as a result of failure to mount a Th1-mediated curative response, although T cells remained capable of secreting IFN-γ and macrophages of producing nitric oxide. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  10. 5850
    “…BACKGROUND: Protozoan parasites of the genus Leishmania are causative agents of a diverse spectrum of human diseases collectively known as leishmaniasis. These eukaryotic pathogens that diverged early from the main eukaryotic lineage possess a number of unusual genomic, molecular and biochemical features. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  11. 5851
    “…Visceral leishmaniasis is a potentially fatal infectious disease caused by the protozoan parasite Leishmania infantum/chagasi in the New World, or by L. donovani or L. infantum/chagasi in the Old World. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  12. 5852
  13. 5853
    “…BACKGROUND: Nearly 1300 cases of leishmaniasis have been identified in American military personnel deployed to Iraq and Afghanistan. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  14. 5854
  15. 5855
  16. 5856
  17. 5857
    “…The L. braziliensis HASP-like proteins (named the orthologous (o) HASPs) are predominantly expressed on the plasma membrane in amastigotes and are recognised by immune sera taken from 4 out of 6 leishmaniasis patients tested in an endemic region of Brazil. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  18. 5858
    “…OBJECTIVES: To support the Bangladesh National Kala-azar Elimination Programme (NKEP), we investigated the feasibility of using trained village volunteers for detecting post-kala-azar dermal leishmaniasis (PKDL) cases, using polymerase chain reaction (PCR) for confirmation of diagnosis and treatment compliance by PKDL patients in Kanthal union of Trishal sub-district, Mymensingh, Bangladesh. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  19. 5859
    “…BACKGROUND: Leishmania braziliensis is the main causative agent of cutaneous leishmaniasis in Brazil. Protection against infection is related to development of Th1 responses, but the mechanisms that mediate susceptibility are still poorly understood. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  20. 5860
    “…BACKGROUND: Resistance of Leishmania donovani to pentavalent antimonials, the first-line treatment of visceral leishmaniasis (VL), has become a critical issue worldwide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
Herramientas de búsqueda: RSS